Showing results (51-60 of 554) with videos related to
Sort By:
Pageof 56
The Urologic Clinics of North America|October 23, 2012
The experience with cytotoxic chemotherapy in metastatic castration-resistant prostate cancerMario A Eisenberger, Emmanuel S AntonarakisThe Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|January 21, 2014
Presurgical Unilateral Cleft Lip Anthropometrics and the Presence of Dental AnomaliesGregory S Antonarakis, David M FisherOncotargets and Therapy|November 8, 2019
Darolutamide For Castration-Resistant Prostate CancerDiogo A Bastos, Emmanuel S AntonarakisFuture Oncology (London, England)|December 21, 2017
Sipuleucel-T for the treatment of prostate cancer: novel insights and future directionsCatherine E Handy, Emmanuel S AntonarakisExpert Review of Clinical Pharmacology|October 26, 2022
The evolving landscape of PARP inhibitors in castration-resistant prostate cancer: a spotlight on treatment combinationsBenjamin A Teply, Emmanuel S AntonarakisJournal of the National Comprehensive Cancer Network : JNCCN|May 23, 2019
NCCN Guidelines Updates: Management of Prostate CancerJames L Mohler, Emmanuel S AntonarakisDrug Design, Development and Therapy|March 31, 2011
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancerChanning J Paller, Emmanuel S AntonarakisHuman Vaccines & Immunotherapeutics|February 17, 2012
Sipuleucel-T for the treatment of metastatic prostate cancer: promise and challengesChanning J Paller, Emmanuel S AntonarakisCurrent Opinion in Oncology|March 14, 2012
Combining immunological and androgen-directed approaches: an emerging concept in prostate cancer immunotherapyEmmanuel S Antonarakis, Charles G DrakeExpert Review of Molecular Diagnostics|January 11, 2018
CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancerDiogo A Bastos, Emmanuel S AntonarakisPageof 56